Canada Life’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-264
Closed -$18K 2551
2021
Q3
$18K Hold
264
﹤0.01% 2455
2021
Q2
$28K Hold
264
﹤0.01% 2420
2021
Q1
$40K Buy
264
+145
+122% +$23.6K ﹤0.01% 2362
2020
Q4
$20K Hold
119
﹤0.01% 2541
2020
Q3
$19K Hold
119
﹤0.01% 2458
2020
Q2
$25K Hold
119
﹤0.01% 2451
2020
Q1
$22K Hold
119
﹤0.01% 2355
2019
Q4
$28K Buy
+119
New +$22.9K ﹤0.01% 2431
2019
Q3
Sell
-176
Closed -$34K 2327
2019
Q2
$34K Hold
176
﹤0.01% 2523
2019
Q1
$46K Hold
176
﹤0.01% 2273
2018
Q4
$34K Buy
+176
New +$53.6K ﹤0.01% 2474

Other funds holding TECX

Canada Life's TECX Position: Q4 2021 in Review

Canada Life sold out of Tectonic Therapeutic (TECX) in Q4 2021, closing a stake of 264 shares — an estimated $18K sold.

Canada Life first reported a position in TECX in Q4 2018 and held it in 11 quarters. The position peaked at $46K in Q1 2019. 92 funds tracked by Wall St. Rank hold TECX as of Q4 2021.

  • Canada Life reported no remaining Tectonic Therapeutic position as of Q4 2021 after selling out during the quarter.
  • Canada Life sold 264 Tectonic Therapeutic shares in Q4 2021, an estimated $18K.
  • Canada Life first reported a position in Tectonic Therapeutic in Q4 2018 and held it in 11 quarters.
  • Canada Life's Tectonic Therapeutic position peaked at $46K in Q1 2019.
  • 92 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2021.

Based on Canada Life's 13F filing for Q4 2021, filed 14 Feb 2022.